Gyeong Jae Cho Selected Research

UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase

1/2018	O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.
7/2016	O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gyeong Jae Cho Research Topics

Disease

11	Neoplasms (Cancer) 01/2019 - 07/2003
11	Seizures (Absence Seizure) 04/2013 - 02/2003
10	Inflammation (Inflammations) 01/2020 - 06/2003
8	Ischemia 07/2015 - 09/2002
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020 - 07/2016
5	Glioma (Gliomas) 11/2015 - 03/2011
5	Reperfusion Injury 07/2015 - 10/2003
4	Ganglion Cysts (Ganglion) 10/2017 - 06/2003
4	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2017 - 12/2002
3	Carcinogenesis 01/2018 - 02/2014
3	Acute Lung Injury 01/2018 - 11/2015
3	Fibrosis (Cirrhosis) 09/2015 - 05/2006
3	Mitochondrial Diseases (Mitochondrial Disease) 07/2015 - 05/2006
3	Drug Resistant Epilepsy 12/2006 - 10/2004
2	Neuroinflammatory Diseases 10/2017 - 12/2011
2	Diabetes Mellitus 10/2017 - 06/2003
2	Non-alcoholic Fatty Liver Disease 01/2017 - 07/2015
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 06/2014
2	Obesity 09/2015 - 06/2012
2	Hypoxia (Hypoxemia) 02/2014 - 10/2002
2	Colitis 01/2014 - 01/2013
2	Neuroblastoma 08/2013 - 09/2006
2	Status Epilepticus (Complex Partial Status Epilepticus) 06/2012 - 11/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2006 - 10/2003
2	Brain Injuries (Brain Injury) 10/2005 - 10/2003
1	Sepsis (Septicemia) 01/2020
1	Atherosclerosis 12/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Body Weight (Weight, Body) 10/2017
1	Hyperglycemia 10/2017
1	Neoplasm Metastasis (Metastasis) 07/2017
1	Lung Injury 04/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Cognitive Dysfunction 04/2016

Drug/Important Bio-Agent (IBA)

10	Kainic Acid (Kainate)IBA 04/2013 - 02/2003
7	Carbon MonoxideIBA 04/2017 - 01/2013
5	TristetraprolinIBA 01/2020 - 01/2014
5	Proteins (Proteins, Gene)FDA Link 10/2017 - 07/2003
5	Retinaldehyde (Retinal)IBA 10/2017 - 03/2003
4	Small Interfering RNA (siRNA)IBA 11/2020 - 03/2011
4	thiamine triphosphorate (TTP)IBA 01/2020 - 01/2014
4	ClusterinIBA 01/2018 - 06/2003
4	Streptozocin (Streptozotocin)FDA Link 10/2017 - 06/2003
4	Ethanol (Ethyl Alcohol)IBA 04/2016 - 05/2005
4	ResveratrolIBA 11/2015 - 12/2011
3	Oncogene Proteins (Oncogene Protein)IBA 11/2020 - 07/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2015
3	TransferasesIBA 10/2017 - 07/2017
3	Tacrolimus (Prograf)FDA LinkGeneric 06/2014 - 10/2008
3	Glutamic Acid (Glutamate)FDA Link 04/2013 - 03/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 10/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2006 - 10/2004
3	Betaxolol (Kerlon)FDA LinkGeneric 10/2003 - 09/2002
2	NAD (NADH)IBA 01/2020 - 07/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 10/2017
2	AcetylglucosamineIBA 01/2019 - 01/2017
2	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 01/2018 - 07/2016
2	Heme Oxygenase-1IBA 01/2018 - 05/2006
2	NFATC Transcription FactorsIBA 10/2017 - 05/2014
2	CytokinesIBA 04/2017 - 01/2014
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2017 - 07/2015
2	Cilostazol (Pletal)FDA LinkGeneric 01/2016 - 07/2015
2	LipopolysaccharidesIBA 11/2015 - 06/2014
2	NF-kappa B (NF-kB)IBA 09/2015 - 12/2011
2	Sirtuin 1IBA 09/2015 - 07/2015
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2015 - 12/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2015 - 12/2011
2	CalcineurinIBA 06/2014 - 10/2008
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2012 - 11/2010
2	Caspase 3 (Caspase-3)IBA 05/2012 - 11/2010
2	deoxyuridine triphosphateIBA 05/2012 - 11/2010
2	Messenger RNA (mRNA)IBA 12/2011 - 07/2003
2	CaspasesIBA 03/2011 - 06/2009
2	Neuroprotective AgentsIBA 10/2009 - 10/2003
2	Nitric Oxide Synthase (NO Synthase)IBA 02/2006 - 10/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2006 - 10/2002
1	GelsolinIBA 11/2020
1	UbiquitinIBA 11/2020
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2020
1	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2020
1	Cyclic ADP-Ribose (cADPR)IBA 01/2020
1	ApolipoproteinsIBA 12/2019
1	Scarlet Red (Sudan IV)IBA 12/2019
1	O-GlcNAc transferaseIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 12/2018
1	FlavonoidsIBA 12/2018
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	QuercetinIBA 12/2018
1	SterolsIBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Liver X ReceptorsIBA 01/2018
1	pterostilbeneIBA 01/2018
1	CXC ChemokinesIBA 07/2017
1	Interleukin-10 (Interleukin 10)IBA 04/2017
1	PyrinIBA 04/2017

Therapy/Procedure

7	Ketogenic Diet 12/2011 - 02/2003
2	Therapeutics 06/2014 - 10/2004
1	Intraperitoneal Injections 10/2017